Moderna Secures $590 Million Subsidy for Advanced Vaccine Development
The U.S. Department of Health and Human Services (HHS) has announced a significant investment of approximately $590 million in Moderna to accelerate the growth of mRNA-based vaccines against pandemic influenza, particularly the H5N1 avian flu. This funding comes amid growing concerns over the spread of the virus in both cows and birds,and also its potential … Read more